| 2025-02-20 | -19.5% | legal | SEC EDGAR | GKOS 8-K: 2.02, 7.01 (SEC Filing) |
| 2025-02-21 | -18.9% | earnings | Yahoo Finance | GKOS Stock Falls Despite Q4 Earnings & Revenue Beat, Margins Decline - Yahoo Finance |
| 2025-10-30 | +15.0% | earnings | Seeking Alpha | Glaukos outlines $600M–$620M 2026 revenue outlook as Epioxa launch and iDose TR drive growth |
| 2025-10-30 | +15.0% | earnings | Seeking Alpha | Glaukos Corporation (GKOS) Q3 2025 Earnings Call Transcript |
| 2025-10-30 | +15.0% | news | The Motley Fool | Why Glaukos Stock Zoomed Almost 14% Higher on Thursday - The Motley Fool |
| 2025-10-20 | -14.0% | expansion | Seeking Alpha | Glaukos falls as Medicare administrator contractors meeting draws concern |
| 2025-10-20 | -14.0% | news | Yahoo Finance | Glaukos Corporation (GKOS) Eye Treatment Epioxa Poised for Strong Market Uptake, Says Stifel - Yahoo Finance |
| 2025-10-20 | -14.0% | earnings | Stock Titan | FDA‑approved incision‑free topical therapy: Glaukos' Epioxa cleared for keratoconus, commercial Q1 2026 - Stock Titan |
| 2025-10-20 | -14.0% | news | Insider Monkey | Glaukos Corporation (GKOS) Eye Treatment Epioxa Poised for Strong Market Uptake, Says Stifel - Insider Monkey |
| 2025-10-20 | -14.0% | legal | TipRanks | Why Glaukos Shares Tumbled Despite FDA Approval - TipRanks |
| 2025-10-29 | +13.9% | earnings | Seeking Alpha | Glaukos Non-GAAP EPS of -$0.16 beats by $0.10, revenue of $133.5M beats by $10.95M |
| 2025-10-29 | +13.9% | legal | SEC EDGAR | GKOS 8-K: 2.02, 7.01 (SEC Filing) |
| 2023-05-03 | +12.7% | legal | SEC EDGAR | GKOS 8-K: 2.02, 7.01 (SEC Filing) |
| 2025-04-30 | -11.7% | earnings | Seeking Alpha | Glaukos Non-GAAP EPS of -$0.22 beats by $0.13, revenue of $106.66M beats by $3.88M |
| 2025-04-30 | -11.7% | legal | SEC EDGAR | GKOS 8-K: 2.02, 7.01 (SEC Filing) |
| 2025-04-30 | -11.7% | earnings | GuruFocus | Glaukos (GKOS) Reports Surpassing Revenue Expectations in Q1 | G - GuruFocus |
| 2026-01-16 | +10.0% | earnings | StocksToTrade | Glaukos Sees Revenue Surge as Analysts Raise Price Targets - StocksToTrade |
| 2026-02-17 | +9.9% | earnings | Seeking Alpha | Glaukos Non-GAAP EPS of -$0.28 misses by $0.08, revenue of $143.1M beats by $6.08M |
| 2026-02-17 | +9.9% | legal | SEC EDGAR | GKOS 8-K: 2.02, 7.01 (SEC Filing) |
| 2021-05-05 | -9.8% | legal | SEC EDGAR | GKOS 8-K: 2.02 and (SEC Filing) |
| 2026-02-18 | +9.6% | news | Seeking Alpha | Glaukos outlines 2026 sales target of $600M–$620M as iDose TR and Epioxa drive growth momentum |
| 2026-02-18 | +9.6% | earnings | Seeking Alpha | Glaukos Corporation (GKOS) Q4 2025 Earnings Call Transcript |
| 2026-02-18 | +9.6% | analyst | Investing.com | Stifel reiterates Glaukos stock rating on product momentum - Investing.com |
| 2026-02-18 | +9.6% | analyst | Investing.com | Needham raises Glaukos stock price target on iDose, Epioxa growth - Investing.com |
| 2026-02-18 | +9.6% | analyst | GuruFocus | BTIG Reiterates Buy Rating for Glaukos (GKOS) with Unchanged Pri - GuruFocus |
| 2026-02-18 | +9.6% | news | StocksToTrade | Glaukos Stock Shoots Up After iDose TR Re-administration Approval - StocksToTrade |
| 2026-02-18 | +9.6% | earnings | Kalkine Media | Glaukos (NYSE:GKOS) Jumps After Qtrly Revenue Beat - Kalkine Media |
| 2025-05-01 | -9.2% | news | Seeking Alpha | Glaukos projects 2025 sales in the $475M-$485M range with strong iDose ramp |
| 2025-05-01 | -9.2% | earnings | Seeking Alpha | Glaukos Corporation (GKOS) Q1 2025 Earnings Call Transcript |
| 2023-11-01 | -8.9% | legal | SEC EDGAR | GKOS 8-K: 2.02, 7.01 (SEC Filing) |
| 2024-05-01 | +8.8% | legal | SEC EDGAR | GKOS 8-K: 2.02, 7.01 (SEC Filing) |
| 2025-09-12 | -8.3% | news | Seeking Alpha | Glaukos' Pipeline And High Valuation: A Risky Hold With Long-Term Upside |
| 2025-09-12 | -8.3% | news | Seeking Alpha | Glaukos' Pipeline And High Valuation: A Risky Hold With Long-Term Upside (NYSE:GKOS) - Seeking Alpha |
| 2022-11-02 | -8.1% | legal | SEC EDGAR | GKOS 8-K: 2.02, 7.01 (SEC Filing) |
| 2025-07-30 | -7.7% | earnings | Seeking Alpha | Glaukos Non-GAAP EPS of -$0.24 beats by $0.02, revenue of $124.1M beats by $8.62M |
| 2025-07-30 | -7.7% | legal | SEC EDGAR | GKOS 8-K: 2.02, 7.01 (SEC Filing) |
| 2022-05-04 | -6.4% | legal | SEC EDGAR | GKOS 8-K: 2.02, 7.01 (SEC Filing) |
| 2025-07-31 | -6.4% | earnings | Seeking Alpha | Glaukos Corporation 2025 Q2 - Results - Earnings Call Presentation |
| 2025-07-31 | -6.4% | earnings | Seeking Alpha | Glaukos Corporation (GKOS) Q2 2025 Earnings Call Transcript |
| 2024-01-09 | +5.9% | legal | SEC EDGAR | GKOS 8-K: 2.02, 7.01 (SEC Filing) |
| 2021-11-04 | +5.8% | legal | SEC EDGAR | GKOS 8-K: 2.02 and (SEC Filing) |
| 2026-03-17 | +5.5% | executive | Stock Titan | GLAUKOS (GKOS) COO reports 2,462-share tax withholding, holds 88,847 shares - Stock Titan |
| 2026-03-17 | +5.5% | news | Stock Titan | Glaukos (NYSE: GKOS) CDO reports tax-withholding of 1,074 shares - Stock Titan |
| 2026-03-17 | +5.5% | legal | Stock Titan | [144] GLAUKOS Corp SEC Filing - Stock Titan |
| 2026-01-13 | -5.2% | earnings | Seeking Alpha | Glaukos reports preliminary Q4 results |
| 2026-01-13 | -5.2% | legal | SEC EDGAR | GKOS 8-K: 2.02, 7.01 (SEC Filing) |
| 2026-01-13 | -5.2% | earnings | Stock Titan | Eye-care maker Glaukos hits 36% Q4 sales jump, targets $600M+ 2026 - Stock Titan |
| 2021-09-15 | +4.9% | legal | SEC EDGAR | GKOS 8-K: 8.01 (SEC Filing) |
| 2022-02-22 | +4.7% | legal | SEC EDGAR | GKOS 8-K: 2.02, 7.01 (SEC Filing) |
| 2025-11-11 | +4.5% | news | Seeking Alpha | Glaukos Corporation (GKOS) Presents at UBS Global Healthcare Conference 2025 Transcript |
| 2026-01-20 | +4.2% | executive | Investing.com | Burns, Glaukos chairman & ceo, sells $31.6 million in GKOS stock - Investing.com |
| 2026-01-14 | +4.1% | earnings | Seeking Alpha | Glaukos falls on preliminary Q4 iDose sales |
| 2026-01-14 | +4.1% | news | Seeking Alpha | Biggest stock movers Wednesday: INTC, TCOM, GKOS, and more |
| 2026-01-14 | +4.1% | news | Seeking Alpha | Glaukos Corporation (GKOS) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript |
| 2026-01-14 | +4.1% | news | Seeking Alpha | Biggest stock movers Wednesday: INTC, TCOM, GKOS, and more (RIVN:NASDAQ) - Seeking Alpha |
| 2026-01-14 | +4.1% | news | Benzinga | Glaukos, Trip.com Group And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session - Benzinga |
| 2024-11-04 | -4.0% | legal | SEC EDGAR | GKOS 8-K: 2.02, 7.01 (SEC Filing) |
| 2026-01-22 | -3.9% | earnings | Seeking Alpha | ClearBridge Small-Cap Growth trims Duolingo, Biohaven, QLYS; Adds PTGX, SSD, BETA, DYN in Q4 |
| 2026-01-22 | -3.9% | news | Yahoo Finance | What Makes Glaukos (GKOS) a Good Investment? - Yahoo Finance |
| 2026-04-01 | +3.9% | earnings | MarketBeat | SG Americas Securities LLC Purchases 49,492 Shares of Glaukos Corporation $GKOS - MarketBeat |
| 2026-03-25 | +3.6% | executive | Stock Titan | Glaukos (NYSE: GKOS) CFO sale and tax share withholdings detailed - Stock Titan |
| 2026-03-25 | +3.6% | news | Stock Titan | Glaukos (NYSE: GKOS) CDO has shares withheld to cover tax obligations - Stock Titan |
| 2026-03-25 | +3.6% | news | Stock Titan | Glaukos (NYSE: GKOS) insider plans sale of 2,511 vested shares - Stock Titan |
| 2025-09-25 | -3.6% | news | Seeking Alpha | Glaukos breaks ground on $80M R&D, manufacturing facility in Alabama |
| 2026-03-23 | +3.5% | analyst | AD HOC NEWS | Glaukos Corp Stock Faces Monthly Pressure Amid Analyst Optimism and Glaucoma Innovation Push - AD HOC NEWS |
| 2026-01-29 | -3.2% | news | Finviz | Here's Why You Should Retain Glaukos Stock in Your Portfolio Now - Finviz |
| 2025-10-01 | +3.1% | news | Seeking Alpha | Glaukos gains as Goldman Sachs initiates at Buy on valuation |
| 2023-02-22 | -3.1% | legal | SEC EDGAR | GKOS 8-K: 2.02, 7.01 (SEC Filing) |
| 2025-04-06 | +3.1% | news | Seeking Alpha | Glaukos: Macro Environment And Limited Market Access Could Stunt Growth Plans |
| 2025-10-21 | -3.1% | news | Investing.com | Glaukos stock falls as Medicare meeting raises reimbursement concerns - Investing.com |
| 2025-11-23 | -3.0% | executive | simplywall.st | Glaukos President & COO Joseph Gilliam Sells 39% Of Holding - simplywall.st |
| 2026-04-02 | +3.0% | news | Stock Titan | GLAUKOS (GKOS) CDO has 5,798 shares withheld to cover RSU tax - Stock Titan |
| 2022-02-07 | +3.0% | legal | SEC EDGAR | GKOS 8-K: 5.02, 7.01 (SEC Filing) |
| 2026-04-03 | +3.0% | news | ChartMill | Glaukos Corp (NYSE:GKOS) Shows High-Growth Momentum and Fits Key Trend Template Rules - ChartMill |
| 2026-04-03 | +3.0% | executive | Stock Titan | Glaukos (NYSE: GKOS) CFO withholds 1,589 shares for RSU tax obligations - Stock Titan |
| 2026-04-03 | +3.0% | news | Stock Titan | Glaukos (NYSE: GKOS) CDO reports RSU tax withholding transactions - Stock Titan |
| 2026-04-03 | +3.0% | news | Stock Titan | Glaukos (GKOS) president uses 3,169 shares to cover tax withholding - Stock Titan |
| 2021-08-05 | +3.0% | legal | SEC EDGAR | GKOS 8-K: 2.02 and (SEC Filing) |
| 2024-02-21 | -2.9% | legal | SEC EDGAR | GKOS 8-K: 2.02, 7.01 (SEC Filing) |
| 2025-11-14 | -2.8% | analyst | The Globe and Mail | Analysts Are Bullish on These Healthcare Stocks: Glaukos (GKOS), Cormedix (CRMD) - The Globe and Mail |
| 2026-02-16 | -2.7% | earnings | DirectorsTalk Interviews | Glaukos Corporation (GKOS) Investor Outlook: Analyzing the 21% Potential Upside Amid Robust Revenue Growth - DirectorsTalk Interviews |
| 2026-02-15 | -2.7% | earnings | Seeking Alpha | Glaukos Q4 2025 Earnings Preview |
| 2025-10-27 | +2.7% | legal | DirectorsTalk Interviews | Glaukos Corporation (GKOS) Stock Analysis: Navigating a 60% Potential Upside in the Medical Devices Sector - DirectorsTalk Interviews |
| 2026-04-21 | -2.7% | news | Simply Wall St. | Vertex And Two More Stocks Possibly Priced Below Their Estimated Worth |
| 2026-04-21 | -2.7% | news | Simply Wall St. | 3 Stocks That May Be Trading Below Their Estimated Intrinsic Value |
| 2026-03-24 | +2.4% | news | Stock Titan | Glaukos (GKOS) affiliate files to sell 1,521 shares after vesting - Stock Titan |
| 2024-06-14 | -2.3% | legal | SEC EDGAR | GKOS 8-K: 3.02, 8.01 (SEC Filing) |
| 2025-12-03 | +2.2% | news | Seeking Alpha | Glaukos Corporation (GKOS) Presents at Citi Annual Global Healthcare Conference 2025 Transcript |
| 2025-09-19 | -2.1% | news | simplywall.st | Here's Why We're Not At All Concerned With Glaukos' (NYSE:GKOS) Cash Burn Situation - simplywall.st |
| 2026-03-29 | +2.1% | legal | Stock Titan | GKOS SEC Filings - Glaukos Corp 10-K, 10-Q, 8-K Forms - Stock Titan |
| 2026-01-31 | -2.1% | news | The Motley Fool | Director Sells GKOS 15,000 Shares for $1.9 Million - The Motley Fool |
| 2025-12-16 | +2.0% | news | Stock Titan | Glaukos (NYSE: GKOS) joins 44th J.P. Morgan Healthcare Conf Jan. 13 - Stock Titan |
| 2026-01-26 | -2.0% | news | Investing.com | Glaukos director Stapley sells $1.9m in GKOS stock - Investing.com |
| 2026-01-26 | -2.0% | news | TradingView | GLAUKOS Corp Executives Engage in Significant Stock Transactions - TradingView |
| 2026-01-23 | -1.8% | news | Investing.com | Gilliam, Glaukos Corp president, sells $561k in Gkos stock - Investing.com |
| 2021-12-20 | +1.7% | legal | SEC EDGAR | GKOS 8-K: 5.02, 7.01 (SEC Filing) |
| 2026-04-16 | +1.7% | news | Zacks | Glaukos Wins Permanent J-Code for Epioxa Keratoconus Therapy |
| 2026-04-16 | +1.7% | executive | Quiver Quantitative | GLAUKOS Corp ($GKOS) CEO 2025 Pay Revealed - Quiver Quantitative |
| 2026-04-16 | +1.7% | legal | Stock Titan | Glaukos report cites $22M in donations, FDA approval progress - Stock Titan |
| 2026-04-16 | +1.7% | news | Stock Titan | Glaukos (NYSE: GKOS) 2026 proxy outlines board diversity, pay and ESG - Stock Titan |
| 2026-04-22 | -1.6% | news | Simply Wall St. | 3 Stocks That May Be Undervalued By Up To 46.2% |
| 2026-04-22 | -1.6% | news | Simply Wall St. | Alkami Technology And 2 Other Stocks That May Be Undervalued By Investors |
| 2025-04-24 | +1.6% | news | Stock Titan | GKOS Stock Price, News & Analysis - Stock Titan |
| 2025-10-28 | +1.5% | earnings | Seeking Alpha | Glaukos Q3 2025 Earnings Preview |
| 2026-04-06 | +1.5% | news | Stock Titan | Glaukos brings Epioxa symposium and 9 eye-care studies to ASCRS - Stock Titan |
| 2026-04-06 | +1.5% | news | Xã Vĩnh Công | Is Glaukos Corporation (GKOS) Stock Trending Down | Price at $112.31, Down 0.41% - Trending Social Stocks - Xã Vĩnh Công |
| 2025-06-24 | +1.4% | news | Seeking Alpha | Glaukos Corporation: Delivering Consistent Growth |
| 2025-06-24 | +1.4% | news | Seeking Alpha | Glaukos Corporation: Delivering Consistent Growth (NYSE:GKOS) - Seeking Alpha |
| 2026-03-02 | -1.4% | earnings | DirectorsTalk Interviews | Glaukos Corporation (GKOS) Stock Analysis: Potential 11.95% Upside Amid Robust Revenue Growth - DirectorsTalk Interviews |
| 2024-08-02 | +1.3% | legal | SEC EDGAR | GKOS 8-K: 2.02 and (SEC Filing) |
| 2026-04-20 | -1.3% | news | Simply Wall St. | Discovering Three Stocks Possibly Priced Below Intrinsic Value Estimates |
| 2026-04-20 | -1.3% | news | DirectorsTalk Interviews | Glaukos Corporation (GKOS) Stock Analysis: A Medical Device Innovator with 11.32% Potential Upside - DirectorsTalk Interviews |
| 2023-08-02 | -1.3% | legal | SEC EDGAR | GKOS 8-K: 2.02, 7.01 (SEC Filing) |
| 2024-12-03 | -1.3% | legal | SEC EDGAR | GKOS 8-K: 1.01 and (SEC Filing) |
| 2022-08-03 | -1.1% | legal | SEC EDGAR | GKOS 8-K: 2.02, 7.01 (SEC Filing) |
| 2026-02-19 | -1.1% | earnings | TIKR.com | Glaukos Stock Jumps 13% After Q4 Beat: Here’s What Its 2026 Guidance Signals - TIKR.com |
| 2025-09-18 | +1.0% | legal | Yahoo Finance | Glaukos Corporation (GKOS) Advances Next-Gen Glaucoma and Corneal Therapies, Eyes FDA Approval for Epioxa - Yahoo Finance |
| 2024-06-05 | +0.9% | legal | SEC EDGAR | GKOS 8-K: 5.02, 5.07 (SEC Filing) |
| 2026-04-10 | -0.9% | news | Stock Titan | Glaukos (NASDAQ: GKOS) affiliate sale reported in Form 144 - Stock Titan |
| 2026-01-06 | +0.8% | earnings | simplywall.st | Glaukos Corporation's (NYSE:GKOS) Shift From Loss To Profit - simplywall.st |
| 2026-04-14 | -0.8% | earnings | MarketBeat | Glaukos Corporation (NYSE:GKOS) Given Consensus Recommendation of "Moderate Buy" by Analysts - MarketBeat |
| 2026-04-14 | -0.8% | news | Stock Titan | [Form 4] GLAUKOS Corp Insider Trading Activity - Stock Titan |
| 2026-04-08 | +0.7% | earnings | Stock Titan | Glaukos sets April 29 earnings release, webcast after market close - Stock Titan |
| 2026-04-08 | +0.7% | earnings | Cổng thông tin điện tử tỉnh Lào Cai | Is Glaukos Corporation (GKOS) Stock Discounted Now | Price at $120.77, Up 4.96% - Profit Surge - Cổng thông tin điện tử tỉnh Lào Cai |
| 2026-02-23 | -0.6% | earnings | Yahoo Finance | Strong Results with 38.1% Revenue Growth Lifted Glaukos (GKOS) in Q4 - Yahoo Finance |
| 2025-11-28 | +0.6% | earnings | Yahoo Finance | Glaukos (GKOS) Up 20% Since Last Earnings Report: Can It Continue? - Yahoo Finance |
| 2025-07-29 | -0.5% | earnings | Seeking Alpha | Glaukos Q2 2025 Earnings Preview |
| 2026-04-23 | -0.5% | news | Simply Wall St. | Discover BioLife Solutions And 2 Other Stocks That May Be Priced Below Their Estimated Value |
| 2026-04-23 | -0.5% | news | Simply Wall St. | Goosehead Insurance And 2 Other Stocks That May Be Undervalued By The Market |
| 2026-04-23 | -0.5% | earnings | Xã Thanh Hà | GKOS (Glaukos Corporation) posts wider than expected Q4 2025 loss as shares rise 2.61 percent on positive investor sentiment. - Core Business Growth - Xã Thanh Hà |
| 2026-04-23 | -0.5% | earnings | Cổng thông tin điện tử tỉnh Lào Cai | Glaukos Corporation (GKOS) Top Loser | Glaukos Corporation misses EPS estimates by 39.9% - Stock Analysis Community - Cổng thông tin điện tử tỉnh Lào Cai |
| 2026-01-28 | +0.5% | legal | Seeking Alpha | Glaukos rises as FDA greenlights labeling update for iDose TR |
| 2026-01-28 | +0.5% | legal | Seeking Alpha | Glaukos rises as FDA greenlights labeling update for iDose TR - Seeking Alpha |
| 2026-03-27 | -0.5% | news | Stock Titan | Glaukos (NYSE: GKOS) president reports new stock and option grants - Stock Titan |
| 2026-03-27 | -0.5% | news | Stock Titan | GLAUKOS (GKOS) CDO Tomas Navratil earns performance RSU stock awards - Stock Titan |
| 2026-03-27 | -0.5% | executive | Stock Titan | Glaukos (NYSE: GKOS) CFO gets new equity awards and sells shares - Stock Titan |
| 2024-07-31 | -0.4% | legal | SEC EDGAR | GKOS 8-K: 2.02, 7.01 (SEC Filing) |
| 2021-06-09 | +0.2% | legal | SEC EDGAR | GKOS 8-K: 5.02 and 5.07 (SEC Filing) |
| 2024-06-28 | +0.2% | legal | SEC EDGAR | GKOS 8-K: 3.02 and 8.01 (SEC Filing) |
| 2026-03-19 | -0.2% | earnings | Yahoo Finance | Why Is Glaukos (GKOS) Down 14.7% Since Last Earnings Report? - Yahoo Finance |
| 2026-03-19 | -0.2% | news | Stock Titan | [Form 4] GLAUKOS Corp Insider Trading Activity - Stock Titan |
| 2026-03-19 | -0.2% | executive | Stock Titan | Glaukos (NYSE: GKOS) CFO sells 625 shares under 10b5-1 plan - Stock Titan |
| 2026-03-19 | -0.2% | news | Stock Titan | Glaukos (NYSE: GKOS) CDO reports 1,031-share sale and tax withholding - Stock Titan |
| 2026-03-19 | -0.2% | executive | Stock Titan | GLAUKOS (NYSE: GKOS) COO reports tax-withholding of 1,189 vested shares - Stock Titan |
| 2025-04-29 | -0.2% | earnings | Seeking Alpha | Glaukos Q1 2025 Earnings Preview |
| 2026-01-05 | +0.1% | legal | DirectorsTalk Interviews | Glaukos Corporation (GKOS) Stock Analysis: A Promising 13.99% Upside in the Medical Devices Sector - DirectorsTalk Interviews |
| 2026-04-15 | -0.1% | news | Stock Titan | New CMS billing code could widen access to Glaukos eye treatment - Stock Titan |
| 2024-10-11 | -0.0% | legal | SEC EDGAR | GKOS 8-K: 8.01 and (SEC Filing) |
| 2026-04-19 | +0.0% | news | Xã Châu Thành | Glaukos Corporation (GKOS) Stock Scrip Dividend (Nudges Up) 2026-04-18 - Community Exit Signals - Xã Châu Thành |
| 2026-04-18 | +0.0% | news | Xã Vĩnh Công | Is Glaukos Corporation (GKOS) stock forming lower lows (+2.61%) 2026-04-18 - Trending Social Stocks - Xã Vĩnh Công |
| 2026-04-24 | — | news | Simply Wall St. | 3 Stocks That Might Be Undervalued By Up To 48.3% Offering A Possible Discount |
| 2026-04-24 | — | news | Simply Wall St. | LSI Industries And 2 Other Stocks That May Be Priced Below Estimated Value |